Company Profile

Public information reviewed
Addex Therapeutics Ltd. logo

Addex Therapeutics Ltd.

Addex Therapeutics Ltd, a biopharmaceutical firm in a developmental phase, operates out of Switzerland, focusing on the discovery, advancement, and commercialization of small-molecule drugs targeting central nervous system (CNS) disorders.

USNASDAQ: ADXN
Follow
More
Reports & analysisAlpha EvalSave PDF
Public sources
1 reviewed
Published leadership records
8
Last reviewed
Sep 13, 2026
View sources

Agent View

Machine representations

Inspect the same governed public record as Markdown, structured data, or a retrieval endpoint.

Canonical entity
alpha:company:1018512c-e9ce-4447-85c5-cf2e3d293a74
Schema
alpha.governance.entity.public.v1
Last reviewed
2026-09-13T04:47:17.357268+00:00
Verification
source_reported
Ownership
unclaimed

Markdown

https://registry.alpha.ac/companies/addex-therapeutics-ltd.md
Open Markdown

Addex Therapeutics Ltd.

Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero.

Record

FieldValue
Representationalpha-profile-markdown-v3
ProtocolAlpha Governance Facts Protocol 0.1
Schemaalpha.governance.entity.public.v1
Record versionpublic-1
Canonical entityalpha:company:1018512c-e9ce-4447-85c5-cf2e3d293a74
Entity typeCompany
Canonical URLhttps://registry.alpha.ac/companies/addex-therapeutics-ltd
PublicationPUBLISHED
Verificationsource_reported
Verification schemaalpha-verification-states-v1
Ownershipunclaimed
Published claims14
Claims under review1
Evidence records2
Conflicts0
Conflicts in internal review0
Observed2026-09-13T04:47:17.357268+00:00
Last reviewed2026-09-13T04:47:17.357268+00:00

Identity

  • Legal name: Addex Therapeutics Ltd.
  • Display name: Addex Therapeutics Ltd.

Leadership

  • Vincent Lawton: Chairman of the Board of Directors. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:1018512c-e9ce-4447-85c5-cf2e3d293a74:2.
  • Isaac Manke: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:1018512c-e9ce-4447-85c5-cf2e3d293a74:2.
  • Jake Nunn: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:1018512c-e9ce-4447-85c5-cf2e3d293a74:2.
  • Raymond Hill: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:1018512c-e9ce-4447-85c5-cf2e3d293a74:2.
  • Roger Mills: Chief Medical Officer and Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:1018512c-e9ce-4447-85c5-cf2e3d293a74:2.
  • Tim Dyer: Chief Executive Officer and Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:1018512c-e9ce-4447-85c5-cf2e3d293a74:2.
  • Roger Mills: Chief Medical Officer and Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:1018512c-e9ce-4447-85c5-cf2e3d293a74:2.
  • Tim Dyer: Chief Executive Officer and Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:1018512c-e9ce-4447-85c5-cf2e3d293a74:2.

Roles

  • PUBLISHED

Governance

  • NOT_ASSERTED

Board committees

  • PUBLISHED

Financials

  • NOT_ASSERTED

Workforce

  • NOT_ASSERTED

Market and index context

  • PUBLISHED

Legal Name

  • Addex Therapeutics Ltd.. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:1018512c-e9ce-4447-85c5-cf2e3d293a74:1.

Headquarters

  • US. Publication: UNDER_REVIEW. Verification: source_reported. Assertion: source_reported. Evidence: unlinked, under review.

Entity Status

  • Public listing published. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:1018512c-e9ce-4447-85c5-cf2e3d293a74:1.

Published Fact

  • US. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:1018512c-e9ce-4447-85c5-cf2e3d293a74:1.
  • CH. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:1018512c-e9ce-4447-85c5-cf2e3d293a74:1.
  • Healthcare. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:1018512c-e9ce-4447-85c5-cf2e3d293a74:1.
  • Biotechnology. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:1018512c-e9ce-4447-85c5-cf2e3d293a74:1.

Coverage states

FieldValue
IdentityPUBLISHED
BusinessPUBLISHED
LeadershipPUBLISHED
Board and committeesPUBLISHED
GovernanceNOT_ASSERTED
FinancialsNOT_ASSERTED
WorkforceNOT_ASSERTED
OwnershipNOT_ASSERTED
RatingsNOT_PUBLISHED
Market and index contextPUBLISHED

Public sources

Rights

FieldValue
public_retrievalallowed
agent_retrievalallowed
redistributionnot_granted
model_trainingnot_granted
commercial_usenot_specified
relationship_pathfindingnot_granted
direct_contactnot_granted

Limitations

  • Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
  • Only explicitly published canonical company identity and current confirmed public roles are included.
  • Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
  • Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
  • This Company Profile is an identity and evidence record, not an Alpha rating.

Alternate representations